首页> 外文期刊>The American Journal of the Medical Sciences >Ghrelin inhibits insulin release by regulating the expression of inwardly rectifying potassium channel 6.2 in islets
【24h】

Ghrelin inhibits insulin release by regulating the expression of inwardly rectifying potassium channel 6.2 in islets

机译:Ghrelin通过调节胰岛内向整流钾通道6.2的表达来抑制胰岛素释放

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction: The objective is to investigate the influence of ghrelin administration on both the insulin secretion and the expression of ATP-sensitive K + channels in islet. Methods: Ghrelin and [D-Lys 3] growth hormone releasing peptide-6 were administered via intraperitoneal injection in Wistar rats at the doses 10 and 10 μmol/kg/d for 2 weeks, respectively. Then glucose tolerance tests were performed and plasma insulin concentrations were measured. Islets were isolated for insulin release experiments. Single β cells were isolated for electrophysiological experiments. Determination of the Kir6.2 and SUR1 mRNA and protein expression levels in islets was performed by polymerase chain reaction and western blotting. Results: Intraperitoneal administration of exogenous ghrelin significantly (P 0.05) increased blood glucose concentrations, attenuated insulin responses during glucose tolerance tests, reduced insulin release from the isolated islets induced by 11.1 and 16.7 mmol/L glucose, hyperpolarized the resting membrane potential and increased the Kir6.2 mRNA and protein expression levels. In contrast, counteraction of ghrelin by intraperitoneal injection of [D-Lys 3] growth hormone releasing peptide-6 significantly (P 0.05) attenuated the aforementioned changes. SUR1 expression levels were not altered in this study. Conclusions: Ghrelin via pancreatic growth hormone secretagogue receptor up-regulates the Kir6.2 expression in islet by hyperpolarizing the resting membrane potential which results in the inhibition of insulin release.
机译:简介:目的是研究生长激素释放肽对胰岛胰岛素分泌和ATP敏感性K +通道表达的影响。方法:分别以10和10μmol/ kg / d的剂量通过Wistar大鼠腹腔注射Ghrelin和[D-Lys 3]生长激素释放肽6,持续2周。然后进行葡萄糖耐量测试并测量血浆胰岛素浓度。分离胰岛用于胰岛素释放实验。分离单个β细胞用于电生理实验。通过聚合酶链反应和蛋白质印迹法测定胰岛中Kir6.2和SUR1 mRNA和蛋白表达水平。结果:腹膜内施用外源性生长激素释放肽(P <0.05)显着提高血糖浓度,在葡萄糖耐量测试期间减弱胰岛素反应,减少11.1和16.7 mmol / L葡萄糖诱导的离体胰岛胰岛素释放,使静息膜电位超极化并增加Kir6.2 mRNA和蛋白质表达水平。相比之下,通过腹膜内注射[D-Lys 3]生长激素释放肽6来抑制生长素释放肽的作用显着(P <0.05)减弱了上述变化。在这项研究中,SUR1表达水平没有改变。结论:Ghrelin通过胰腺生长激素促分泌素受体使胰岛膜电位超极化,从而上调了胰岛中Kir6.2的表达,从而抑制了胰岛素的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号